Showing results (601-610 of 689) with videos related to

Sort By:
Pageof 69
Nature Communications|December 3, 2020
The transcriptome of circulating sexually committed Plasmodium falciparum ring stage parasites forecasts malaria transmission potentialSurendra K Prajapati, Ruth Ayanful-Torgby, Zuleima Pava, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2006
Potencies of human immunodeficiency virus protease inhibitors in vitro against Plasmodium falciparum and in vivo against murine malariaKatherine T Andrews, David P Fairlie, Praveen K Madala, et al.
Plos Neglected Tropical Diseases|May 1, 2012
A research agenda for helminth diseases of humans: towards control and eliminationBoakye A Boatin, María-Gloria Basáñez, Roger K Prichard, et al.
The American Journal of Tropical Medicine and Hygiene|January 11, 2019
WASH for WORMS: A Cluster-Randomized Controlled Trial of the Impact of a Community Integrated Water, Sanitation, and Hygiene and Deworming Intervention on Soil-Transmitted Helminth InfectionsSusana Vaz Nery, Rebecca J Traub, James S McCarthy, et al.
The Journal of Clinical Investigation|February 12, 2020
A Plasmodium vivax experimental human infection model for evaluating efficacy of interventionsKatharine A Collins, Claire Yt Wang, Matthew Adams, et al.
Malaria Journal|September 20, 2019
Loss of complement regulatory proteins on red blood cells in mild malarial anaemia and in Plasmodium falciparum induced blood-stage infectionDamian A Oyong, Jessica R Loughland, Arya SheelaNair, et al.
Ebiomedicine|June 8, 2024
Longitudinal changes in iron homeostasis in human experimental and clinical malariaStephen D Woolley, Matthew J Grigg, Louise Marquart, et al.
Plos One|April 18, 2012
The frequency of malaria is similar among women receiving either lopinavir/ritonavir or nevirapine-based antiretroviral treatmentTina S Skinner-Adams, Alice S Butterworth, Kimberly A Porter, et al.
British Journal of Cancer|September 1, 2011
Erlotinib 'dosing-to-rash': a phase II intrapatient dose escalation and pharmacologic study of erlotinib in previously treated advanced non-small cell lung cancerA C Mita, K Papadopoulos, M J A de Jonge, et al.
Atherosclerosis|December 20, 2017
Genetic variants in PPARGC1B and CNTN4 are associated with thromboxane A2 formation and with cardiovascular event free survival in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)Nina S McCarthy, Ciara Vangjeli, Praveen Surendran, et al.
Pageof 69